Delivery Order SPE2DB20D1004-SPE2DB25FNLCA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a contract value of $3,157.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 16, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lyrica 100 mg capsules (90-count) with a ceiling value of $1,213.60. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded, non-set-aside contract. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,972.10 for 90 capsules of Lyrica 100 mg on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The order will be performed at...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lyrica 100 mg capsules (quantity: 90 units) with a ceiling value of $2,514.26. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract is scheduled for ultimate completion on...
- The Defense Logistics Agency awarded a delivery order valued at $1,183.60 to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) valued at $2,530.67. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was awarded competitively with no set-aside designation, and the...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This non-set-aside, competitively awarded contract employs firm fixed price terms with an ultimate completion date of August 27, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,342.80 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lyrica 50 mg capsules (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a ceiling value of $1,853.49. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is non-competitive and issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNLCADelivery Order
The Defense Logistics Agency awarded a $2,148.59 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Lyrica 225 mg capsules (90-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 29, 2025, with performance to take place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The parent IDC provides a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support defense healthcare programs worldwide. This specific delivery order for Lyrica, a neurological treatment medication, exemplifies the company's role in fulfilling pharmaceutical procurement needs for the Defense Health Agency and other federal healthcare systems through the flexible IDC mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/26/25 |